Quantinno Capital Management’s Avidity Biosciences RNAM Stock Holding History

Quantinno Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,235	Closed	-$810K	–	3369
2025 Q4	$810K	Buy	11,235 +240	+2%	+$15.5K	﹤0.01%	1968
2025 Q3	$479K	Buy	10,995 +3,232	+42%	+$131K	﹤0.01%	2057
2025 Q2	$220K	Buy	+7,763	New	+$231K	﹤0.01%	2279
2025 Q1	–	Sell	-7,026	Closed	-$204K	–	2140
2024 Q4	$204K	Buy	7,026 +518	+8%	+$21.6K	﹤0.01%	1533
2024 Q3	$299K	Sell	6,508 -80	-1%	-$3.47K	﹤0.01%	1266
2024 Q2	$269K	Buy	+6,588	New	+$189K	﹤0.01%	1192

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Quantinno Capital Management's RNAM Position: Q1 2026 in Review

Quantinno Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 11,235 shares — an estimated $810K sold.

Quantinno Capital Management first reported a position in RNAM in Q2 2024 and held it in 6 quarters. The position peaked at $810K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Quantinno Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Quantinno Capital Management sold 11,235 Avidity Biosciences shares in Q1 2026, an estimated $810K.
Quantinno Capital Management first reported a position in Avidity Biosciences in Q2 2024 and held it in 6 quarters.
Quantinno Capital Management's Avidity Biosciences position peaked at $810K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.